A session at the AHA Scientific Sessions 2025 focused on clinical trials related to cutting edge valve and coronary care.
Panelists considered the technology relatively safe but weren’t swayed by the “statistical gymnastics” needed to find a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback